Literature DB >> 4212405

The effect of hydergine on the transit time of cerebral circulation in diffuse cerebral insufficiency.

B Mongeau.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4212405     DOI: 10.1007/bf00560377

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  18 in total

1.  ISOTOPE STUDY OF BRAIN BLOOD TURNOVER IN VASCULAR DISEASE.

Authors:  W H OLDENDORF; M KITANO
Journal:  Arch Neurol       Date:  1965-01

2.  Measurement of the mean transit time of cerebral circulation by external detection of an intravenously injected radioisotope.

Authors:  W H OLDENDORF
Journal:  J Nucl Med       Date:  1962-09       Impact factor: 10.057

3.  Bilateral studies of cerebral oxygen uptake in young and aged normal subjects and in patients with organic dementia.

Authors:  N A LASSEN; I FEINBERG; M H LANE
Journal:  J Clin Invest       Date:  1960-03       Impact factor: 14.808

4.  Aspects of the pathology of presenile dementia.

Authors:  A Torvik
Journal:  Acta Neurol Scand       Date:  1970       Impact factor: 3.209

5.  The actions of Hydergine on the brain. A histochemical, circulatory and neurophysiological study.

Authors:  H Emmenegger; W Meier-Ruge
Journal:  Pharmacology       Date:  1968       Impact factor: 2.547

6.  Angiographic and isotope pool circulation study of the cerebral hemispheres after internal carotid artery occlusion.

Authors:  E K Lang; E C Hann
Journal:  Dis Chest       Date:  1965-09

7.  A double-blind investigation of hydergine in the treatment of cerebrovascular insufficiency in the elderly.

Authors:  D B Rao; J R Norris
Journal:  Johns Hopkins Med J       Date:  1972-05

8.  An ergot alkaloid preparation (hydergine) versus placebo for treatment of symptoms of cerebrovascular insufficiency: double-blind study.

Authors:  W G Jennings
Journal:  J Am Geriatr Soc       Date:  1972-08       Impact factor: 5.562

9.  [Determinants estimating cerebral functions after long term therapy with hydergin].

Authors:  U Herzfeld; W Christian; J Ronge; M Wittgen
Journal:  Arztl Forsch       Date:  1972-06-10

10.  An ergot alkaloid preparation (hydergine) in geriatric therapy.

Authors:  J Roubicek; C Geiger; K Abt
Journal:  J Am Geriatr Soc       Date:  1972-05       Impact factor: 5.562

View more
  1 in total

1.  Uncoupling of cerebral blood flow and glucose utilization by dihydroergocristine in the conscious rat.

Authors:  T Beck; P Vogg; J Krieglstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-07       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.